Search for:
Author

David Campos

Browsing
David Campos is a senior associate of the Healthcare & Life Sciences Practice Group of Baker McKenzie’s Mexico City office. David joined the Firm in 2019 after completing an LL.M. in Global Health Law and a Certificate in Food and Drug Law at Georgetown University Law Center (Washington, DC). David has more than seven years of experience advising clients in connection with regulation of life sciences and general corporate matters of the pharmaceutical industry.
In Latin America

Mexico: Major change to the regulatory approval system for biosimilars, medicines and medical devices

by and 4 Mins Read

On 31 May 2021, the Mexican President published on the Federal Official Gazette a major amendment to the Secondary Regulations for Health Supplies (Reglamento de Insumos para la Salud, “RIS”) (“Decree”). The Decree is effective as of 1 June 2021, affecting both medicines and medical devices. It improves the regulatory environment.

In Employment

Mexico: Increased enforcement of notification obligations by health authorities in manufacturing sites of all industries, regarding operations, physician rooms and dining rooms

by , and 4 Mins Read

There is a clear increase of enforcement actions taken by health authorities, both at the Federal and State level, where authorities are verifying if both physician and dining rooms at manufacturing plants, from all industries, have been properly supported by the applicable Notices of Operation. At the same time, many local health authorities are unduly requesting companies to have a Notice of Operation for their manufacturing operations. Companies shall comply the former and be prepared to reject the latter in order to prevent disruptions of operations and future sanctions.